What Researchers Did
Researchers conducted a randomized controlled trial to compare systemic steroids alone versus systemic steroids combined with hyperbaric oxygen therapy for idiopathic sudden sensorineural hearing loss.
What They Found
The hearing improvement rate was 64% in the group receiving systemic steroids plus hyperbaric oxygen therapy, compared to 56% in the group receiving systemic steroids alone, a difference that was not statistically significant (p = 0.369). The addition of hyperbaric oxygen therapy did not significantly improve hearing outcomes, although a descending audiogram curve was identified as an unfavorable prognostic factor, leading to a 30 dB lower hearing gain.
What This Means for Canadian Patients
Canadian patients with sudden sensorineural hearing loss may not experience additional hearing improvement from hyperbaric oxygen therapy when combined with standard systemic steroid treatment. This suggests that current steroid-based treatments remain a primary approach, and the added cost and effort of HBOT may not be justified for this condition.
Canadian Relevance
This study has no direct Canadian connection as it was not conducted in Canada, nor does it involve Canadian researchers or patients.
Study Limitations
A potential limitation of this study is the relatively small sample size of 50 patients, which might limit the power to detect subtle treatment differences.